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Two new mixed ligands metal complexes of sulphadoxine and pyramethamine were prepared by using 
CuCl2.6H2O and FeCl3.6H2O. The complexes were characterized by elemental analysis, melting point 
determination, molar conductivity, metal content analysis (AAS), IR, magnetic susceptibility 
measurements and UV-Visible spectroscopy. Based on the analytical and spectroscopic data, the 
complexes were proposed to have the formulae [M1L1L2(Cl)2] and [M2L1L2(Cl)3] (where M1 = Cu(II), M2 = 
Fe(III)), L1 = sulphadoxine, L2 = pyramethamine). The spectroscopic data proposed L1 to be a 
monodentate ligand and coordinated through N atom of the NH2 group in both complexes. Also, L2 was 
proposed to be tridentate ligand and coordinated through N atom of the NH2 groups and through N 
atom of imine group. However, [M1L1L2(Cl)2] and [M2L1L2(Cl)3] were proposed to possess distorted 
octahedral geometry. Conductivity measurement values supported the non-electrolytic nature of the 
complexes. The complexes have been tested in vitro against a number of pathogenic bacteria [g(+) 
Escherichia coli, g(+) Proteus species, g(+) Pseudomonas aeruginosa and g(+) Salmonella typhi] by 
using disc diffusion method. Obtained results indicated that the metal complexes exhibited better 
antibacterial activities as compared to the ligands. Toxicology tests against some tissues of albino rat 
(Rattus novergicuss) revealed toxicity of the complexes in the kidney as compared to the parent drugs. 
[M1L1L2(Cl)2] was found to be toxic to the sera, livers and  kidneys of the rats used, while [M2L1L2(Cl)3] 
was found to be non-toxic to the sera, livers and kidneys of the rats as their alkaline phosphatase 
(ALP) values showed non-significant difference to the control values. 
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INTRODUCTION 
 
Malaria remains the major killer disease in the developing 
countries that affects lives of more than 500 million 
people and kills about two million of them annually (Snow 
et al., 2005). Most of the drugs that are used to treat 
malaria can be broadly grouped into 4-aminoquinolines, 
8-aminoquinolines, anti-folates, artemisinin derivatives 
and certain class of antibiotics, such as doxycycline and 
clindamycin. 4-aminoquiniline derivatives, such as chloro-
quine and  amodiaquine,  have  been  the  first-line  drugs  
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against malaria for past several decades. Development of 
resistance against these drugs in several parts of world 
necessitated the use of other drugs along with it for 
efficient treatment. Malaria treatment guidelines issued 
by World Health Organisation (WHO) also recommends 
the use of amodiaquine along with sulphadoxine-
pyramethamine combinations for the treatment of 
chloroquine-resistant malaria (Mishra et al., 2011). With 
the evolution of chloroquine resistance to malaria para-
sites in Africa and South-east Asia, the combination of the 
antifolate drugs pyrimethamine (PYR) and sulphadoxine 
(SDX), was one of the mainstays of anti-malarial drug 
therapy. Although, the resistance is now widespread, it is  
 
 
 
 
still used in Africa, sometimes in combination with the 
artemisinin derivative, artesunate, to treat uncomplicated 
malaria (Nosten and White, 2007). PYR and SDX 
synergistically inhibit enzyme activities of the folate 
biosynthesis pathway, namely dihydrofolate reductase 
(DHFR) and dihydropteroate synthetase (DHPS). The 
action of antifolate drugs, the genetic basis of parasite 
resistance, and the complexities of the relationships 
between parasite genotype and in vivo and in vitro drug 
response phenotypes have been comprehensively 
investigated (Hyde, 2005; Nzila, 2006). Antimicrobial 
resistance is fast becoming a global concern. The 
emergence of resistance is an evolutionary process that 
is based on selection of organisms that have enhanced 
ability to survive dose that are considered to be lethal. 
Resistance results from a mutation in the parasite 
chromosome or the acquisition of extra-chromosomal 
DNA (Trampuz et al., 2003). The spread of resistant 
parasite strains to all kinds of drugs is growing high in 
tropical and sub-tropical regions, including Africa, Asia 
and part of America (Sachs and Malaney, 2002). The 
medicinal uses and applications of metals and metal 
complexes are of increasing clinical and commercial 
importance. The introduction of metal ions into 
chemotherapy agents with the aim of increasing their 
efficacy has been an extensive research area for more 
than three decades since the discovery of Cis-platin 
(Farrell, 2003; Fahmideh et al., 2010; Ajibade, 2008). The 
metallo-elements play vital roles at the molecular level in 
a living system. In the search for novel therapy against 
resistant organism, the modification of existing drug by 
combination to a metal centre has gained attention in 
recent years (Delhaes et al., 2001). The efficacies of 
some therapeutic agents are known to increase upon co-
ordination, thus metal-based drug is seen as promising 
alternatives for possible replacement for some of the 
current drugs. Metal complexes as pharmaceuticals have 
received considerable attention in the development of 
anticancer agents using platinum, ruthenium and other 
metals, with greater efficacy and reduced toxic side 
effects (Timerbaev et al., 2006). Vanadium compounds, 
either alone or in combination with other agents, have the 
potential to serve as anti-diabetic agents (Roat-Malone, 
2007; Ajibola et al., 1998). Despite the existence of 
various chemotherapeutic options available to man, 
malaria epidemic is still stronger than ever. Even though 
several agents are under clinical trials, the field of 
inorganic chemistry can still offer better hope for the 
future. Thus, the search for new anti-resistant therapies is 
of high priority. In continuation of our search for new 
chemotherapic agents, we synthesize novel metal com-
plexes of pyramethamine mixed with sulphadoxine. 
 
 
EXPERIMENTAL 
 
Sulphadoxine and pyramethamine (product of Sigma Chemical Co., 
USA) were obtained  from  Bond  Chemical,  Lagos,  Nigeria.  Other  
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reagents are product of Aldrich & Sigma, Co., UK.  They were used 
without further purification. The metal sources are CuCl2.6H2O and 
FeCl3.6H2O.  Melting points were determined using Gallenkamp 
melting point apparatus. The UV-Vis spectra measurements were 
obtained from solution of the compounds in dimethylformamide 
(DMF) on Thermo Genesys 10UV scanning UV-Vis spectrometer. 
Magnetic susceptibility measurements of the complexes in the solid 
state were determine by Gouy balance using Hg[Co(NCS)4] as a 
calibrant. Infrared (IR) spectra of the samples in KBr pellets were 
obtained in the ranges of 400 to 4000 cm-1 using Thermo-Nicolet 
FT-IR Spectrometer (Covenant University, Nigeria). Conductivity 
measurement was carried out in DMF using Hand-held conductivity-
TDS meter. Microanalyses for C, H, O and N were performed on 
Perkin Elmer 204C micro-analyser. Metal content was measured by 
Thermo S-Series Atomic Absorption Spectrometer (AAS). Isolates 
of g(-) E. coli, P. aureginosa, S. typhi and Proteus spp. were 
obtained from Microbiological Department, Covenant University, 
Nigeria. Albino rats (Rattus novergicuss) were obtained from 
Biochemistry Department, Covenant University (Nigeria). 
 
 
Synthesis of metal complexes 
 
0.6206 g (2 mmol) of sulphadoxine and 0.500 g (2 mmol) of 
pyramethamine were dissolved separately in 20 ml of ethanol 
(Elzahany et al., 2008). The solutions were mixed thoroughly 
together in round bottom flask. The resulting mixture was stirred 
under reflux for 1 h at 60°C, after which 0.01 mol of each of the 
metal salt in 20 ml methanol was added. The reaction mixture was 
refluxed for 3 h, after which the solution was allowed to cool to 
room temperature and left on the bench for 2 weeks. The crystals 
formed were filtered under vacuum, washed twice with ethanol and 
dried in desiccator containing CaCl2 as drying agent. The purity of 
the compounds was confirmed by using thin layer chromatography 
(TLC). 
 
 
Antibacterial screening 
 
The antibacterial activities of the ligands and the metal complexes 
were studied against four human pathogenic bacterial, namely: g(-) 
E. coli g(+) S. aureus, P. aureginosa and S. typhi (Collins and Lyne, 
1980; Watson, 2000; Garba and Salihu, 2011). The filter disc 
diffusion method was adopted. Both sulphadoxine and 
pyramethamine were used separately as standard. Nutrient agar (5 
g nutrient broth; 3.1 g of nutrient agar in 200 ml of sterile water for 8 
plates) was prepared and used as basal medium for the cultured 
bacterial and were autoclaved. The paper discs impregnated with 
the test compounds were placed on the solidified medium. The 
plates were pre-incubated for 1 h at room temperature and 
incubated at 37°C for 24 h. The observed zone of inhibition in 
percentage was determined according to the Equation that follows: 
 
% Inhibition = (Average diameter of bacterial colony on the test 
plate (mm)) / (Average diameter of growth of bacterial colony on the 
control plate (mm)) × 100 
 
 
Toxicology study 
 
A total of twenty-five albino rats of Wistar strain weighing between 
150 to 180 g housed in clean metabolic cages, were used for 
toxicology study (Yakubu et al., 2005; Tella and Obaleye, 2010; 
Ogunniran et al., 2007). They were well feed with rat pellets and tap 
water. They were grouped into five groups consisting of five 
animals in each group. Group A (control) administered with 
methanol, Group B, C, D and E were administered accordingly with 
sulphadoxine (L1), pyramethamine (L2), Cu(L1)(L2)Cl2 and
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Table 1. Colour, decomposition temperature, conductivities and analytical data of the ligands L1 and L2 and their mixed ligands metal complexes. 
 
Compound 
Carbon found 
(Calc.) 
Hydrogen found 
(Calc.) 
Oxygen found 
(Calc.) 
Nitrogen found 
(Calc.) 
Metal found 
(Calc) 
Conductivity  
(Ω-1cm2mol-1) 
Melting point 
(°C) 
Colour state Yield (%) 
Sulphadoxine (L1) 46.17 (46.44)  4.01 (4.22)  20.32 (20.62)  18.03 (18.06)  - 4.55 191-192 - - 
Pyramethamine (L2) 57.89 (57.95)  4.44 (4.46)  - 22.50 (22.52)  - 3.37 193-194 - - 
Cu(L1L2)Cl2 41.25 (41.62)  3.21 (3.49)  9.10 (9.22)  16.00 (16.15)  9.02 (9.16)  2.63 199 White crystal 53 
Fe(L1L2)Cl3 39.89 (39.96)  3.32 (3.35) 8.81 (8.87)  15.39 (15.53)  7.29 (7.74)  2.37 216 Brown crystal 46 
 
 
 
Fe(L1)(L2)Cl3. They were administered intravenously two 
times daily for 5 days at the dose level of 3.33 mg/kg body. 
All the rats were sacrificed 24 h after the last day of 
administration. Their kidneys and livers were harvested 
and kept inside sucrose solution separately and were 
stored in iced cold 0.25 M sucrose solution. The blood 
samples were collected into clean centrifuge tubes. 
 
 
Preparation of serum and tissue homogenate 
 
The method described by Tella and Obaleye (2010) was 
adopted. The blood samples in the centrifuge tubes were 
then centrifuged for 15 min using Uniscope Laboratory 
Centrifuge (model SM 800B, England). The sera were then 
aspirated using Pasteur pipette into clean dried sample 
bottles after which they were stored for further analysis. 
The kidneys and livers were decapulated, blotted in tissue 
paper and were weighed. They were homogenized and 
stored in the freezer for further use. The alkaline 
phosphatase (ALP) activity was determined (Yakubu et al., 
2005) and statistical significance was determined using 
Duncan multiple range test and values were considered 
statistically significant at P < 0.05. 
 
 
RESULTS AND DISCUSSION 
 
Physical characteristics and elemental analysis 
(CHN) of the ligands and Cu(II) and Fe(III) 
complexes prepared are presented in Table 1. 
The results of C, H and N percentages are in 
accordance with the composition suggested for 
the two complexes. The solubility of the metal 
complexes was compared with the ligands by 
dissolving them in some polar solvents, such as 
water, methanol, ethanol, acetone and non-polar 
solvents, e.g.  n-hexane, benzene and DMF. The 
two complexes were found to be non-soluble in 
distilled water, methane, ethanol and n-hexane. 
However, they were found to be soluble in 
acetone, benzene and DMF. This is an indication 
that the complexes are non-polar in nature (Vogel, 
1989). The two complexes were coloured and 
possess high melting points. They are amorphous 
and stable in air. Hence, the proposed stoichio-
metric equation for the synthesized complexes 
could be represented as: 
 
 MCln.6H2O + L1 + L2 → ML1L2Cln + 6H2O 
 
where M = Cu(II) for n= 2 and Fe(III) for n=3,  L1 = 
Sulphadoxine and L2 = pyramethamine.  
 
 
Conductance measurements 
 
The conductivity of the complexes was measured 
in DMF. The complexes showed molar 
conductance values ranging from 2.37 Ωcm
2
mol
-1
 
indicating their non-electrolytic nature (Vogel, 
1989). The obtained values suggested that no 
anion is present outside the coordination sphere. 
Infrared spectra 
 
The infrared spectra of the ligands were 
compared with those of metal complexes (Table 
2). The infrared spectra data of the ligands and 
their metal complexes are in agreement with the 
expected range. The strong band in the range of 
3410 to 3682 cm
-1
 was attributed to (N-H) 
stretching vibration (Fessenden and Fessenden, 
1990; Fahmideh et al., 2010). The same band 
was observed in the metal complexes spectra at 
lower wavelength [Cu(L1L2)Cl2] (3598 cm
-1
) and in 
[Fe(L1L2)Cl3]  (3600 cm
-1
). The shifting of this 
group to lower frequency when compared with the 
two free ligands suggesting a coordination of 
Cu(II) and Fe(III) ion, respectively through 
nitrogen atom of the respective amine group 
(Farrell, 2003; Elzahany et al., 2008). However, 
this observation was confirmed by C-N bending 
vibration which appeared as medium band at 
1170 cm
-1
 in L1 and at 1080 cm
-1
 in L2. The band 
was observed to have shifted to lower frequency 
(1050 cm
-1
) in both complexes coupled with 
reduction in intensity. The appearance of C-N 
bending at this position further supports the 
involvement of nitrogen atoms in complexation 
with metal ions under investigation (Fahmideh et 
al., 2010). Also, the infrared spectra display strong 
band at 500 cm
-1
 [Cu(L1L2)Cl2]  and at 730 cm
-1
 
[Fe(L1L2)Cl3] attributed to M-N vibration (McCleverty
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Table 2. IR Spectra (4000-400 cm-1) of the ligands L1 and L2 and their mixed metal complexes. 
 
Compound Ѵ(N-H) cm-1 Ѵ(C-H) cm-1 Ѵ(C=C) cm-1 Ѵ(C-N) cm-1 Ѵ(C-O) cm-1 Ѵ(S=O) cm-1 L-M 
L1 
3682.01
s
 
3010
s,b
 1580.07
s
 1170.03
m
 1210.01
s,b
 1190.27s - 
3600.10
s
 
        
L2 
3605.07
s
 
3010
s,b
 
1600.01
s
 
1080.12
vw
 1220.03
s,b
 - - 
3410.01
s
 1510.07
s
 
        
Cu(L1L2)Cl2 3598.02
s
 3005.10
s,b
 
1525.17
s
 1078.11
m
 
1200.03
s,b
 1185.26
m
 504.17
s
 
1420.01
s
 1050.32
m
 
        
Fe(L1L2)Cl3 3600.01
m
 3005.21
s
 
1520.07
m
 
1050.02
w
 1310.22
vw
 1200.20
s,b
 730.34
s
 
1420.12
m
 
 
w- weak, s-strong, m-medium, vw- very weak, vs-very strong, m,b- medium and broad, s,b- strong and broad. 
 
 
 
Table 3. UV-Vis spectra assignments of sulphadoxine, pyramethamine and their mixed metal complexes. 
 
Compound Wavelength (nm) (cm
-1
) Tentative assignment µeff B.M. 
L1 
202 49504 π- π* 
- 
271 36900 n- π* 
     
L2 
202 49504 π- π* 
- 
286 34965 n- π* 
     
Cu(L1L2)Cl2 
486 20576 
2
Eg(D)→
2
T2g(D) 1.5 
347 26041 π- π*
  
230 43478 n- π* 
 
    
 
Fe(L1L2)Cl3 
495 27624 
6
A1g→
4
T2g(G) 5.4 
362 39682 
6
A1g →
4
T1g(G)
  
 
g-gerade 
 
 
 
and Meyer, 2003). The band was conspicuously absent in 
the spectra of the ligands. The appearance of M-N 
vibration further supports the involvement of nitrogen in 
the complexation. Other bands observed in the spectra of 
the ligands were also observed in the metal complexes 
with shifting in their position due to the effect of 
complexation. 
 
 
Electronic absorption spectra and magnetic moment 
 
The electronic absorption data of the ligands and the 
metal complexes are as shown in Table 3. L1 showed two 
absorption bands at 202 and 271 nm, while L2 showed 
similar bands at 202 and 286 nm. The bands were 
assigned to π- π* transition of C=C of the phenyl rings 
and n-π* transitions of C-N and C-O groups (Obaleye et 
al., 2001; Vogel, 1989). However, the bands were 
observed to have undergone bathochromic shift in the 
metal complexes due to complexation. The electronic 
transition of [Cu(L1L2)Cl2] complex shows two weak 
bands at 230, 347 and a broad band at 486 nm 
corresponding to n- π*, π- π* and 
2
Eg(D)→
2
T2g(D) 
transition, respectively. The band at 486 nm is expected 
for d-d transition of Cu(II) complex (McCleverty and 
Meyer, 2003; Heslop and Jones, 1986). The broadness 
of the band could be attributed to the overlapping of 
several bands as a result of strong Jahn-Teller distortion 
expected in a d
9
 ion (Ajibade et al., 2006). However, 
molar conductance value for the complex in DMF (14.63 
Ω
-1
cm
2
mol
-1
) shows that the chloride ions are coordinated 
to the Cu(II) ion (Douglas et al., 1999). Thus, the 
electronic absorbance data supports a distorted 
octahedral geometry (Youssef and Hegab, 2005). The 
Cu(II) complex showed µeff value of 1.5 B.M., indicative of 
one unpaired electron per Cu(II) ion.  This  suggests  that 
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Scheme 1. Proposed structure of (Fe(III) and Cu(II) complexes of sulphadoxine 
mixed with pyramethamine. 
 
 
 
the complex has structure within the range consistent to 
spin-free distorted octahedral geometry. The electronic 
transition of [Fe(L1L2)Cl3] showed two weak and broad 
absorption bands at 362 and 495 nm corresponding to 
6
A1g→
4
T1g(G) and 
6
A1g→
4
T2g(G) transitions, 
respectively. The transitions are consequence of very 
weak forbidden transitions to excited states of spin 
multiplicity other than 6, and thus favour distorted 
octahedral geometry around metal ions with the apical 
positions occupied by two coordinated chloride atom. The 
third chloride atom was proposed to be outside the 
coordination sphere. This was confirmed by the 
precipitation of white precipitate when the solution of the 
complex was treated with AgNO3 solution. However, the 
magnetic moment of Fe(III) complex was found to be 5.4 
B.M. indicating high spin state of the complex (Tella and 
Obaleye, 2010; Cotton and Wilkinson, 1981). 
Combining spectral data, elemental analyses and 
analytical data were used to arrive at the proposed 
structure as shown in Scheme 1. 
 
 
Results of antimicrobial study 
 
The results of biological activity of the ligands and the 
metal complexes against some strains of micro-
organisms are as shown in Figures 1 to 3. The diameters 
of zone of inhibition (mm) for the ligands were found to be 
in the range of 37.12 to 48.12 mm for the four bacteria 
used. They were found to be averagely active. However, 
the overall results for metal complexes indicate that the 
two complexes show better activity than the ligands 
against all the organisms used under the same experi-
mental conditions. This suggests that the chelation could 
n
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Figure 1. Zone of inhibition (%) of the ligands and metal complexes 
against E. coli. 
 
 
 
 
 
Figure 2. Zone of inhibition (%) of the ligands and metal complexes 
against Proteus spp. 
 
 
 
 
 
Figure 3. Zone of inhibition (%) of the ligands and metal complexes 
against P. aureginose. L1=Sulphadoxine, L2=Pyramethamine. 
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Figure 4. Results of toxicology test of the ligands and the metal 
complexes against liver homogenate. 
 
 
 
 
 
Figure 5. Results of toxicology test of the ligands and the metal 
complexes against kidney homogenate. 
 
 
 
facilitate the ability of a complex to cross a cell 
membrane. Also, chelation could moderately enhance the 
lipophilic character of the compounds and thus 
subsequently favour its permeability through the cell 
membrane. The passage of molecules across cellular 
barriers increases with lipophilicity and that the most 
lipophilic compounds will have the highest intestinal 
absorption (Garba and Salihu, 2011). 
 
 
Results of toxicology assay 
 
The values of ALP activities in the kidney, liver and 
serum following the administration of ligands and their 
mixed metal complexes as compared to the control are 
as shown in Figures 4 to 6. The results indicated that 
sera, livers and kidneys of the rats administered with 
[Cu(L1L2)Cl2] produced significant increase (P < 0.05) in 
ALP activities, while the  ALP  activities  values  for  sera, 
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Figure 6. Results of toxicology test of the ligands and the metal 
complexes against sera. 
 
 
 
livers and kidneys of the rats administered with 
[Fe(L1L2)Cl3] were found to be non-significantly (P < 0.05) 
different from the control values. The trend confirmed 
alteration in the enzymes activity of the kidneys, livers 
and sera due to the presence of [Cu(L1L2)Cl2]. The 
alteration may likely be damage to their plasma 
membrane thus leading to leakages of membrane 
components into the extracellular fluid (Yakubu et al., 
2005; Tella and Obaleye, 2010; Ogunniran et al., 2008) 
and therefore increased their enzymes activity 
abnormally. However, the non-significant changes 
observed in ALP activities of the livers, kidneys and sera 
against [Fe(L1L2)Cl3] suggested partial non-damage effect 
of   the   metal   complex   to  them. It   can therefore be 
concluded that [Cu(L1L2)Cl2] is toxic as compared to 
control at the dosage level used, while [Fe(L1L2)Cl3]  is 
non-toxic. 
 
 
Conclusion 
 
Reviews on anti-malarial drugs have shown that there are 
three consistent ways in which we believe antimalarial 
drug resistance emerges (Ian, 2004). Spontaneous drug-
resistant mutations have affected the effectiveness of 
direct drug treatment. Therefore it is important to 
recognize the possibility of considering metal drugs as 
potential therapeutic agent. The present study shows the 
feasibility and justification for synthesis of mixed 
antibiotics metal complexes using sulphadoxine and 
pyramethamine as ligands. Cu(II) and Fe(III) complexes 
of pyramethamine mixed with sulphadoxine have been 
successfully synthesized and characterized by spectral 
and analytical data. Based on these data, distorted octa-
hedral geometry has been assigned to the complexes. In 
the complexes, sulphadoxine was pro-posed to co-
ordinate   through  N  atom   of   the  amine   group  while 
 
 
 
 
pyramethamine was to coordinate through an N atom of 
imine and N atom of the two amine groups. Thus, 
sulphadoxine has been proposed to be a monodentate 
ligand, while pyramethamine was proposed to be 
tridentate ligands. However, from the analytical data 
obtained, the complexes possessed better physical 
properties as compared to the parent drugs. The 
antimicrobial results clearly indicate that the complexes 
are much more effective as chemotherapy agents than 
their parent drugs. Therefore, they could be more 
effective against Plasmodium faciparum than the parent 
drugs. However, the complexes are toxic at the dose 
level used to the kidneys, but not to livers and sera of the 
rat administered with the complexes. Thus, the present 
study concluded that complexes could be used as 
potential drug of choice to manage the bacterial diseases 
after critical evaluation of the in vivo effect of the metal 
complexes experimentally on higher animals and are 
subjected to clinical trials. 
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